NCT07241455

Brief Summary

This single-center, prospective observational study aims to translate, culturally adapt, and evaluate the validity and reliability of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx) in Turkish pediatric intensive care settings (cCPAx-TR). We will assess content validity with an expert panel, feasibility in a pilot run, test-retest reliability, internal consistency, and criterion validity against established clinical scores.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 21, 2025

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2025

Completed
Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

3 months

First QC Date

November 17, 2025

Last Update Submit

February 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Test-retest intraclass correlation coefficient (ICC) - total cCPAx-TR score

    The intraclass correlation coefficient (two-way mixed, absolute agreement) for the cCPAx-TR total score between two assessments administered 48 hours apart in clinically stable participants.

    two measurements conducted 48 hours apart

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study will include pediatric patients aged 2 to 18 years who are admitted to the pediatric intensive care unit (PICU) at Göztepe Prof. Dr. Süleyman Yalçın City Hospital. The study population represents critically ill children with various underlying medical, surgical, and neurological conditions who are clinically stable enough to undergo bedside physical function assessment. Both intubated and non-intubated patients will be eligible for inclusion, provided that they meet stability and safety criteria for evaluation.

You may qualify if:

  • Children aged 2 to 18 years
  • Admitted to the pediatric intensive care unit (PICU)
  • Clinically stable for bedside assessment
  • Parental or guardian informed consent obtained (and child assent when appropriate)
  • Able to perform or be observed for at least one item of the cCPAx-TR

You may not qualify if:

  • Unstable hemodynamics or severe hypoxemia that prevents safe assessment
  • Deep sedation or neuromuscular blockade that prevents observation at both assessments
  • Severe orthopedic or neurological conditions (for example, unstable fractures or acute paralysis) that prohibit safe mobilization
  • Expected death or withdrawal of care within 24 hours
  • Refusal of consent by parents or guardians

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Göztepe Prof. Dr. Süleyman Yalçın City Hospital

Istanbul, Kadıkoy, 34000, Turkey (Türkiye)

Location

Study Officials

  • Muhterem Duyu

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Critical Care Fellow, Department of Pediatrics

Study Record Dates

First Submitted

November 17, 2025

First Posted

November 21, 2025

Study Start

September 1, 2025

Primary Completion

December 1, 2025

Study Completion

December 10, 2025

Last Updated

February 11, 2026

Record last verified: 2026-02

Locations